Evofem Bioscience Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 9,561 | 4,952 | 4,825 | 845 | 7,104 |
| Cost of Goods | 2,592 | 905 | 755 | 365 | 1,512 |
| Gross Profit | 6,969 | 4,047 | 4,070 | 480 | 5,592 |
| Operating Expenses | 4,216 | 4,001 | 6,076 | 518 | 7,107 |
| Operating Income | 3,345 | 951 | -1,251 | 327 | -1,003 |
| Other Income | -558 | -2,524 | -526 | 629 | -2,034 |
| Pre-tax Income | 2,787 | -1,573 | -1,777 | 956 | -3,037 |
| Income Tax | -1 | -4 | 7 | N/A | N/A |
| Net Income Continuous | 2,788 | -1,569 | -1,784 | 956 | -3,037 |
| Net Income | $2,788 | $-1,569 | $-1,784 | $956 | $-3,037 |
| EPS Basic Total Ops | 0.02 | -0.01 | -0.02 | 0.01 | 0.05 |
| EPS Basic Continuous Ops | 0.02 | -0.01 | -0.02 | 0.01 | 0.05 |
| EPS Diluted Total Ops | 0.03 | -0.01 | -0.02 | 0.00 | 0.07 |
| EPS Diluted Continuous Ops | 0.03 | -0.01 | -0.02 | 0.00 | 0.07 |
| EPS Diluted Before Non-Recurring Items | 0.00 | -0.01 | -0.02 | 0.00 | -0.03 |
| EBITDA(a) | $3,452 | $1,069 | $-1,116 | $593 | $-642 |